Findings from a new clinical trial add to a growing evidence base for the potential of cannabinoids in managing diabetes. What do we know so far? The rise in people living with type 2 diabetes is an impending global health crisis. According to the World Health [...]
Acclaimed Global CBD brand, Elixinol, is making a highly anticipated return to the UK market thanks to a partnership with BRITISH CANNABIS. This exciting development was made possible by the 2022 licensing and distribution agreement entered into with BRITISH CANNABIS a leading UK-based company. With this [...]
Copyright © 2020 – 2026 | The Cannabis Pages | All Rights Reserved | Important Notice | The Cannabis Pages “TCP” is an information resource for medical cannabis patients and prescribers. Nothing on the site should be construed as a promotion or inducement. TCP does not promote any product or represent that the products mentioned on TCP’s website are treatment for any kind of medical condition. TCP cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Cannabis is an unlicensed medication which can only be administered under the supervision of a licensed physician.
